PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
macroPROTAC-2 BPL-201413 macroPROTAC-2

VHL

BRD2
BRD3
BRD4

Inquiry

Molecular Weight: 1074.72

Molecular Formula: C52H64ClN9O10S2

Description: It is a macrocyclic PROTAC by adding a cyclizing linker to the BET degrader MZ1. It enhances the degradation potency and selectivity between homologous targets.

MT-797 BPL-201414 MT-797 2231744-12-8

CRBN

BTK

Inquiry

Molecular Weight: 787.83

Molecular Formula: C41H41N9O8

Boiling Point: 1026.4±65.0°C at 760 Torr

Density: 1.51±0.1 g/cm3

Description: It is a PROTAC that induces degradation of both wild-type and C481S mutant BTK.

JBJ-07-038 BPL-201415 JBJ-07-038 2140806-72-8

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 975.07

Molecular Formula: C50H51FN8O10S

Density: 1.437±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

MT-783 BPL-201416 MT-783 2231744-26-4

CRBN

BTK

Inquiry

Molecular Weight: 743.78

Molecular Formula: C39H37N9O7

Boiling Point: 1008.6±65.0°C at 760 Torr

Density: 1.54±0.1 g/cm3

Description: It is a PROTAC that induces degradation of both wild-type and C481S mutant BTK.

JBJ-07-200 BPL-201417 JBJ-07-200

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 977.06

Molecular Formula: C50H50F2N8O9S

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(17-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201418 2-(6-(4-(4-(17-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-66-0

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 1056.17

Molecular Formula: C54H57N9O12S

Density: 1.392±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(2-((4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)amino)-2-oxoethyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201419 2-(6-(4-(4-(2-((4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)butyl)amino)-2-oxoethyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-67-1

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 952.06

Molecular Formula: C50H49N9O9S

Density: 1.414±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201420 2-(6-(4-(4-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-79-5

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 865.03

Molecular Formula: C48H48N8O6S

Density: 1.387±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201421 2-(6-(4-(4-(8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-81-9

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 893.08

Molecular Formula: C50H52N8O6S

Density: 1.359±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(3-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanoyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201422 2-(6-(4-(4-(3-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanoyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-70-6

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 880.98

Molecular Formula: C47H44N8O8S

Density: 1.450±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(3-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)propanoyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201423 2-(6-(4-(4-(3-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)propanoyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-69-3

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 925.04

Molecular Formula: C49H48N8O9S

Density: 1.430±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201424 2-(6-(4-(4-(1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-71-7

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 1013.14

Molecular Formula: C53H56N8O11S

Density: 1.396±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15-pentaoxaoctadecan-18-oyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201425 2-(6-(4-(4-(1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15-pentaoxaoctadecan-18-oyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-64-8

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 1057.18

Molecular Formula: C55H60N8O12S

Density: 1.382±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(4-(4-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201426 2-(6-(4-(4-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)piperazin-1-yl)phenyl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide 2140806-83-1

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 897.03

Molecular Formula: C48H48N8O8S

Density: 1.409±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-(2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide BPL-201427 2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-(2-hydroxyphenyl)-N-(thiazol-2-yl)acetamide 2140806-76-2

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 958.07

Molecular Formula: C49H51N9O10S

Density: 1.435±0.06 g/cm3

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(6-(4-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201428 2-(6-(6-(4-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 898.02

Molecular Formula: C47H47N9O8S

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201429 2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 942.07

Molecular Formula: C49H51N9O9S

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide BPL-201430 2-(6-(6-(4-(2-(2-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)pyridin-3-yl)-1-oxoisoindolin-2-yl)-2-phenyl-N-(thiazol-2-yl)acetamide

CRBN

EGFR L858R/T790M

Inquiry

Molecular Weight: 943.05

Molecular Formula: C49H50N8O10S

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

(2S,4R)-1-((2S)-3,3-Dimethyl-2-(3-(2-(2-(4-(5-(3-oxo-2-(2-oxo-1-phenyl-2-(thiazol-2-ylamino)ethyl)isoindolin-5-yl)pyridin-2-yl)piperazin-1-yl)ethoxy)ethoxy)propanamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide BPL-201431 (2S,4R)-1-((2S)-3,3-Dimethyl-2-(3-(2-(2-(4-(5-(3-oxo-2-(2-oxo-1-phenyl-2-(thiazol-2-ylamino)ethyl)isoindolin-5-yl)pyridin-2-yl)piperazin-1-yl)ethoxy)ethoxy)propanamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

VHL

EGFR L858R/T790M

Inquiry

Molecular Weight: 1083.35

Molecular Formula: C57H66N10O8S2

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

(2S,4R)-1-((14S)-14-(tert-Butyl)-12-oxo-1-(4-(5-(3-oxo-2-(2-oxo-1-phenyl-2-(thiazol-2-ylamino)ethyl)isoindolin-5-yl)pyridin-2-yl)piperazin-1-yl)-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide BPL-201432 (2S,4R)-1-((14S)-14-(tert-Butyl)-12-oxo-1-(4-(5-(3-oxo-2-(2-oxo-1-phenyl-2-(thiazol-2-ylamino)ethyl)isoindolin-5-yl)pyridin-2-yl)piperazin-1-yl)-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

VHL

EGFR L858R/T790M

Inquiry

Molecular Weight: 1127.39

Molecular Formula: C59H70N10O9S2

Description: It is a mutant-selective allosteric EGFR degrader that is effective against a broad range of drug-resistant mutations.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Inquiry Basket